Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | HNRNPF | Human | (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of HNRNPF protein | CTD | PMID:31195006 | HNRNPF | Human | (Z)-3-butylidenephthalide | decreases expression | EXP | | 6480464 | butylidenephthalide results in decreased expression of HNRNPF protein | CTD | PMID:23770345 | HNRNPF | Human | 1,2-dichloroethane | increases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of HNRNPF mRNA | CTD | PMID:28960355 | HNRNPF | Human | 1,2-dimethylhydrazine | affects expression | ISO | Hnrnpf (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of HNRNPF mRNA | CTD | PMID:22206623 | HNRNPF | Human | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | EXP | | 6480464 | Metribolone promotes the reaction [NDRG1 protein binds to HNRNPF protein] | CTD | PMID:17220478 | HNRNPF | Human | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of HNRNPF protein | CTD | PMID:17152098 | HNRNPF | Human | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Hnrnpf (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | HNRNPF | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hnrnpf (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HNRNPF mRNA | CTD | PMID:21570461 | HNRNPF | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HNRNPF mRNA | CTD | PMID:33387578 | HNRNPF | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of HNRNPF mRNA | CTD | PMID:34747641 | HNRNPF | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of HNRNPF mRNA | CTD | PMID:22574217 | HNRNPF | Human | 2,4-dinitrotoluene | affects expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of HNRNPF mRNA | CTD | PMID:21346803 | HNRNPF | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of HNRNPF mRNA | CTD | PMID:37199045 | HNRNPF | Human | 3H-1,2-dithiole-3-thione | decreases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of HNRNPF mRNA | CTD | PMID:19162173 | HNRNPF | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HNRNPF mRNA | CTD | PMID:36041667 | HNRNPF | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | Fenretinide results in increased expression of HNRNPF mRNA | CTD | PMID:28973697 | HNRNPF | Human | 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | Decitabine results in increased expression of HNRNPF mRNA | CTD | PMID:17908484 | HNRNPF | Human | 5-fluorouracil | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPF mRNA] | CTD | PMID:15016801 | HNRNPF | Human | 6-propyl-2-thiouracil | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of HNRNPF mRNA | CTD | PMID:30047161 | HNRNPF | Human | actinomycin D | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of HNRNPF protein | CTD | PMID:38460933 | HNRNPF | Human | Aflatoxin B2 alpha | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of HNRNPF intron | CTD | PMID:30157460 | HNRNPF | Human | amitrole | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of HNRNPF mRNA | CTD | PMID:30047161 | HNRNPF | Human | ammonium chloride | affects expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of HNRNPF mRNA | CTD | PMID:16483693 | HNRNPF | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of HNRNPF mRNA | CTD | PMID:24449571 | HNRNPF | Human | Aroclor 1254 | decreases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of HNRNPF mRNA | CTD | PMID:23650126 | HNRNPF | Human | benzo[a]pyrene | increases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of HNRNPF mRNA | CTD | PMID:20504355 | HNRNPF | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of HNRNPF promoter | CTD | PMID:27901495 | HNRNPF | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of HNRNPF 3' UTR and Benzo(a)pyrene results in increased methylation of HNRNPF 5' UTR | CTD | PMID:27901495 | HNRNPF | Human | benzo[a]pyrene | multiple interactions | ISO | Hnrnpf (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HNRNPF mRNA | CTD | PMID:27858113 | HNRNPF | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of HNRNPF mRNA | CTD | PMID:20106945 | HNRNPF | Human | benzo[b]fluoranthene | multiple interactions | ISO | Hnrnpf (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HNRNPF mRNA | CTD | PMID:27858113 | HNRNPF | Human | bisphenol A | affects expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of HNRNPF mRNA | CTD | PMID:25181051 | HNRNPF | Human | bisphenol A | decreases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | bisphenol A results in decreased expression of HNRNPF mRNA | CTD | PMID:33221593 | HNRNPF | Human | bisphenol A | multiple interactions | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HNRNPF mRNA and [bisphenol A co-treated with tributyltin] results in increased expression of HNRNPF mRNA | CTD | PMID:31129395 and PMID:36041667 | HNRNPF | Human | bisphenol A | decreases methylation | ISO | Hnrnpf (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of HNRNPF promoter | CTD | PMID:27312807 | HNRNPF | Human | bisphenol A | increases methylation | ISO | Hnrnpf (Mus musculus) | 6480464 | bisphenol A results in increased methylation of HNRNPF promoter | CTD | PMID:27312807 | HNRNPF | Human | bisphenol F | multiple interactions | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HNRNPF mRNA | CTD | PMID:36041667 | HNRNPF | Human | cadmium dichloride | decreases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of HNRNPF mRNA | CTD | PMID:33453195 | HNRNPF | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of HNRNPF mRNA | CTD | PMID:38568856 | HNRNPF | Human | caffeine | decreases expression | EXP | | 6480464 | Caffeine results in decreased expression of HNRNPF protein | CTD | PMID:31195006 | HNRNPF | Human | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of HNRNPF protein | CTD | PMID:35688186 | HNRNPF | Human | carbon nanotube | affects expression | EXP | | 6480464 | Nanotubes and Carbon affects the expression of HNRNPF protein | CTD | PMID:22001959 | HNRNPF | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to HNRNPF gene] | CTD | PMID:28238834 | HNRNPF | Human | chlorpyrifos | decreases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Chlorpyrifos results in decreased expression of HNRNPF mRNA | CTD | PMID:20691718 | HNRNPF | Human | choline | multiple interactions | ISO | Hnrnpf (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HNRNPF gene | CTD | PMID:20938992 | HNRNPF | Human | chrysene | increases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | chrysene results in increased expression of HNRNPF mRNA | CTD | PMID:26377693 | HNRNPF | Human | chrysene | multiple interactions | ISO | Hnrnpf (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HNRNPF mRNA | CTD | PMID:27858113 | HNRNPF | Human | cisplatin | decreases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Cisplatin results in decreased expression of HNRNPF protein | CTD | PMID:22023808 | HNRNPF | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of HNRNPF mRNA | CTD | PMID:19320972 and PMID:19376846 | HNRNPF | Human | copper atom | increases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | Copper results in increased expression of HNRNPF protein | CTD | PMID:21146535 | HNRNPF | Human | copper(0) | increases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | Copper results in increased expression of HNRNPF protein | CTD | PMID:21146535 | HNRNPF | Human | coumarin | increases phosphorylation | EXP | | 6480464 | coumarin results in increased phosphorylation of HNRNPF protein | CTD | PMID:35688186 | HNRNPF | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of HNRNPF mRNA | CTD | PMID:20106945 | HNRNPF | Human | DDE | increases expression | EXP | | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of HNRNPF mRNA | CTD | PMID:38568856 | HNRNPF | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of HNRNPF mRNA | CTD | PMID:37042841 | HNRNPF | Human | doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of HNRNPF protein | CTD | PMID:29385562 | HNRNPF | Human | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of HNRNPF mRNA | CTD | PMID:29803840 | HNRNPF | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HNRNPF protein | CTD | PMID:23301498 | HNRNPF | Human | flutamide | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of HNRNPF mRNA | CTD | PMID:24136188 | HNRNPF | Human | folic acid | multiple interactions | ISO | Hnrnpf (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HNRNPF gene | CTD | PMID:20938992 | HNRNPF | Human | folic acid | decreases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | Folic Acid results in decreased expression of HNRNPF mRNA | CTD | PMID:25629700 | HNRNPF | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of HNRNPF protein | CTD | PMID:37730182 | HNRNPF | Human | gentamycin | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of HNRNPF mRNA | CTD | PMID:22061828 | HNRNPF | Human | glyphosate | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Glyphosate results in increased expression of HNRNPF mRNA | CTD | PMID:26302742 | HNRNPF | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of HNRNPF protein | CTD | PMID:32959892 | HNRNPF | Human | L-methionine | multiple interactions | ISO | Hnrnpf (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HNRNPF gene | CTD | PMID:20938992 | HNRNPF | Human | lovastatin | increases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | Lovastatin results in increased expression of HNRNPF mRNA | CTD | PMID:20493250 | HNRNPF | Human | Mesaconitine | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | mesaconitine results in increased expression of HNRNPF protein | CTD | PMID:37182599 | HNRNPF | Human | methimazole | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of HNRNPF mRNA | CTD | PMID:30047161 | HNRNPF | Human | nefazodone | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of HNRNPF mRNA | CTD | PMID:24136188 | HNRNPF | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of HNRNPF mRNA | CTD | PMID:25583101 | HNRNPF | Human | Nutlin-3 | multiple interactions | EXP | | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of HNRNPF protein | CTD | PMID:38460933 | HNRNPF | Human | ochratoxin A | decreases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | ochratoxin A results in decreased expression of HNRNPF protein | CTD | PMID:19445961 | HNRNPF | Human | oxaliplatin | multiple interactions | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of HNRNPF mRNA | CTD | PMID:25729387 | HNRNPF | Human | ozone | decreases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Ozone results in decreased expression of HNRNPF protein | CTD | PMID:33146391 | HNRNPF | Human | paracetamol | affects expression | ISO | Hnrnpf (Mus musculus) | 6480464 | Acetaminophen affects the expression of HNRNPF mRNA | CTD | PMID:17562736 | HNRNPF | Human | perfluorooctane-1-sulfonic acid | increases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of HNRNPF protein | CTD | PMID:26178269 | HNRNPF | Human | perfluorooctanoic acid | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | perfluorooctanoic acid results in increased expression of HNRNPF mRNA | CTD | PMID:19162173 | HNRNPF | Human | phenethyl isothiocyanate | affects binding | EXP | | 6480464 | HNRNPF protein binds to phenethyl isothiocyanate | CTD | PMID:21838287 | HNRNPF | Human | pirinixic acid | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | pirinixic acid results in increased expression of HNRNPF mRNA | CTD | PMID:19162173 | HNRNPF | Human | pirinixic acid | affects expression | ISO | Hnrnpf (Mus musculus) | 6480464 | pirinixic acid affects the expression of HNRNPF mRNA | CTD | PMID:17950772 | HNRNPF | Human | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of HNRNPF mRNA | CTD | PMID:30047161 | HNRNPF | Human | quinomethionate | affects expression | EXP | | 6480464 | quinomethionate affects the expression of HNRNPF mRNA | CTD | PMID:15387888 | HNRNPF | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of HNRNPF protein | CTD | PMID:37664457 | HNRNPF | Human | silicon dioxide | affects secretion | EXP | | 6480464 | Silicon Dioxide analog affects the secretion of HNRNPF protein | CTD | PMID:25895662 | HNRNPF | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of HNRNPF mRNA | CTD | PMID:38568856 | HNRNPF | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of HNRNPF mRNA | CTD | PMID:34032870 | HNRNPF | Human | sulfadimethoxine | increases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of HNRNPF mRNA | CTD | PMID:30047161 | HNRNPF | Human | sulforaphane | affects binding | EXP | | 6480464 | HNRNPF protein binds to sulforaphane | CTD | PMID:21838287 | HNRNPF | Human | tetrachloromethane | multiple interactions | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | [Olive Oil analog co-treated with Carbon Tetrachloride] affects the expression of HNRNPF protein | CTD | PMID:25303780 | HNRNPF | Human | tetraphene | multiple interactions | ISO | Hnrnpf (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of HNRNPF mRNA | CTD | PMID:27858113 | HNRNPF | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of HNRNPF mRNA | CTD | PMID:38568856 | HNRNPF | Human | titanium dioxide | decreases methylation | ISO | Hnrnpf (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of HNRNPF promoter | CTD | PMID:35295148 | HNRNPF | Human | titanium dioxide | increases methylation | ISO | Hnrnpf (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of HNRNPF gene and titanium dioxide results in increased methylation of HNRNPF promoter | CTD | PMID:35295148 | HNRNPF | Human | topotecan | multiple interactions | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of HNRNPF mRNA | CTD | PMID:25729387 | HNRNPF | Human | tributylstannane | multiple interactions | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of HNRNPF mRNA | CTD | PMID:31129395 | HNRNPF | Human | trichloroethene | increases methylation | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased methylation of HNRNPF gene | CTD | PMID:27618143 | HNRNPF | Human | trichloroethene | decreases expression | ISO | Hnrnpf (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of HNRNPF mRNA | CTD | PMID:33387578 | HNRNPF | Human | triptonide | increases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | triptonide results in increased expression of HNRNPF mRNA | CTD | PMID:33045310 | HNRNPF | Human | trovafloxacin | multiple interactions | ISO | Hnrnpf (Mus musculus) | 6480464 | [trovafloxacin co-treated with lipopolysaccharide and E coli O55-B5] results in decreased expression of HNRNPF mRNA | CTD | PMID:18930950 | HNRNPF | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of HNRNPF gene | CTD | PMID:29154799 | HNRNPF | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of HNRNPF mRNA | CTD | PMID:23179753 and PMID:27188386 | HNRNPF | Human | warfarin | increases expression | ISO | Hnrnpf (Mus musculus) | 6480464 | Warfarin results in increased expression of HNRNPF mRNA | CTD | PMID:20493250 | |
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
